SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aronex Pharma (ARNX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tara Cobble who wrote (24)5/14/1997 8:56:00 PM
From: Dauntless   of 320
 
Tara,

Thanks for the response. I picked up the release early this morning but honestly saw nothing really bad. In fact, I thought it positive that they were acting proactively in determining the additional patient requirements now, rather than after they had filed for approval.

I'm not a pharmaceutical expert but it just didn't seem like the kind of news that warrants a 20 - 25% hit. I think they are adequately capitalized - at least they don't have to pay for these additional patients.

Guess it's just market jitters.

What do you think?

Greg
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News